Accessed July 14, 2021
GLP-1 drugs reduced the odds of new alcohol-use disorders by 18%, cannabis-use disorders by 14%, cocaine use by 20%, nicotine use by 26%, and opioid use by 25%, the researchers found
Improved Joint Health
Postmarketing: injection-site induration, inflammation, pruritus and urticaria
Scroll to view more GLP-1R activation in the pancreas enhances the secretion of insulin when elevated levels of blood glucose are present, and when coupled with GIPR activation in the pancreas, which stimulates beta cells to ramp up insulin production, blood sugar can be more effectively regulated in the treatment of Type 2 diabetes
Interestingly, Glud-MFo-c exhibited a pH-responsive degradation capability in the tumor microenvironment, along with the release of Ce6 and Fe 3 (CN) 6